THEMISMED Stock Overview
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for THEMISMED from our risk checks.
Themis Medicare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹208.50 |
| 52 Week High | ₹263.85 |
| 52 Week Low | ₹132.61 |
| Beta | 0.61 |
| 1 Month Change | -3.98% |
| 3 Month Change | -2.89% |
| 1 Year Change | 50.01% |
| 3 Year Change | 525.47% |
| 5 Year Change | 636.23% |
| Change since IPO | 1,525.10% |
Recent News & Updates
What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You
Dec 27
Themis Medicare (NSE:THEMISMED) Takes On Some Risk With Its Use Of Debt
Dec 01Recent updates
What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You
Dec 27Themis Medicare (NSE:THEMISMED) Takes On Some Risk With Its Use Of Debt
Dec 01Themis Medicare (NSE:THEMISMED) Has Affirmed Its Dividend Of ₹5.00
Aug 18Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Aug 04Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Jul 18We Think Themis Medicare (NSE:THEMISMED) Is Taking Some Risk With Its Debt
Jul 08Themis Medicare (NSE:THEMISMED) Is Due To Pay A Dividend Of ₹5.00
May 18Themis Medicare (NSE:THEMISMED) Seems To Use Debt Quite Sensibly
Dec 21Themis Medicare (NSE:THEMISMED) Has Announced That It Will Be Increasing Its Dividend To ₹5.00
Aug 28Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹5.00
Aug 08Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
Jul 21Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
May 27Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
May 12Calculating The Fair Value Of Themis Medicare Limited (NSE:THEMISMED)
Nov 09Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
Oct 26Increases to Themis Medicare Limited's (NSE:THEMISMED) CEO Compensation Might Cool off for now
Sep 11Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹4.30
Aug 16Do Themis Medicare's (NSE:THEMISMED) Earnings Warrant Your Attention?
Jul 09Estimating The Intrinsic Value Of Themis Medicare Limited (NSE:THEMISMED)
May 14If You Like EPS Growth Then Check Out Themis Medicare (NSE:THEMISMED) Before It's Too Late
Mar 23These 4 Measures Indicate That Themis Medicare (NSE:THEMISMED) Is Using Debt Reasonably Well
Mar 02Why Themis Medicare Limited (NSE:THEMISMED) Is A Top Dividend Stock
Feb 08Themis Medicare Limited's (NSE:THEMISMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 11
Here's What We Think About Themis Medicare's (NSE:THEMISMED) CEO Pay
Dec 14Does Themis Medicare (NSE:THEMISMED) Have A Healthy Balance Sheet?
Nov 16Are You An Income Investor? Don't Miss Out On Themis Medicare Limited (NSE:THEMISMED)
Oct 21Themis Medicare Limited (NSE:THEMISMED) Looks Interesting, And It's About To Pay A Dividend
Sep 13Shareholder Returns
| THEMISMED | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.4% | -2.8% | -1.5% |
| 1Y | 50.0% | 54.9% | 45.0% |
Return vs Industry: THEMISMED underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: THEMISMED exceeded the Indian Market which returned 45% over the past year.
Price Volatility
| THEMISMED volatility | |
|---|---|
| THEMISMED Average Weekly Movement | 7.1% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: THEMISMED has not had significant price volatility in the past 3 months.
Volatility Over Time: THEMISMED's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | 996 | Sachin Patel | www.themismedicare.com |
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics, as well as non-steroidal anti-inflammatory drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001.
Themis Medicare Limited Fundamentals Summary
| THEMISMED fundamental statistics | |
|---|---|
| Market cap | ₹19.19b |
| Earnings (TTM) | ₹452.86m |
| Revenue (TTM) | ₹3.64b |
42.4x
P/E Ratio5.3x
P/S RatioIs THEMISMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| THEMISMED income statement (TTM) | |
|---|---|
| Revenue | ₹3.64b |
| Cost of Revenue | ₹1.28b |
| Gross Profit | ₹2.36b |
| Other Expenses | ₹1.91b |
| Earnings | ₹452.86m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 4.92 |
| Gross Margin | 64.89% |
| Net Profit Margin | 12.44% |
| Debt/Equity Ratio | 26.0% |
How did THEMISMED perform over the long term?
See historical performance and comparison